Network pharmacology approach to evaluate the therapeutic effects of mulberry leaf components for obesity

Wang,Guidan; Dong,Jine

doi:10.3892/etm.2021.10978

Network pharmacology approach to evaluate the therapeutic effects of mulberry leaf components for obesity

Authors:
- Guidan Wang
- Jine Dong
View Affiliations

Affiliations: Health Management Research Laboratory, Hunan Future Health Technology Group Co., Ltd. (Future Health University), Changsha, Hunan 410000, P.R. China
Published online on: November 17, 2021 https://doi.org/10.3892/etm.2021.10978
Article Number: 56
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Obesity is a chronic condition that has become a serious public health challenge globally due to the association with a high incidence of complications. Mulberry leaf is one of the most commonly used medicinal and herbal medicines that has been reported to ameliorate obesity and hyperlipidemia. However, the mechanism remains unclear. In the present study, a network pharmacology approach was used to explore the potential mechanism underlying the effects of mulberry leaf extract on obesity. First, the potential targets of mulberry leaf and obesity were predicted using SwissTargetPrediction, Online Mendelian Inheritance in Man, GeneCards and Comparative Toxicogenomics Database databases, which were then used to construct the protein‑protein interaction networks. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyzes were performed using R version 3.6.3. Finally, results of this network analysis were verified by using the mulberry leaf extract to treat high‑fat diet‑induced obese mice. In total, 24 target genes associated with obesity that could potentially be affected by mulberry leaf treatment were predicted by network pharmacology, using which top seven related pathways were determined by KEGG enrichment analysis. Triglyceride (TG) and total cholesterol (TC) levels in mice serum were detected using TG and TC assay kits. Hepatic fat accumulation was detected by H&E staining whereas liver lipid droplets were detected by Oil red O staining in mice tissues. The expression of IL‑1β, NF‑κB inhibitor α, inducible nitric oxide synthase, AMP‑activated protein kinase (AMPK), sterol regulatory element‑binding proteins and fatty acid synthase in the visceral white adipose tissues of mice was analyzed by western blotting. The expression of TNF‑α, peroxisome proliferator activated receptor (PPAR)D, PPARG, fatty acid amide hydrolase (FAAH) and hydroxysteroid 11‑β dehydrogenase 1 (HSD11B1) in the visceral white adipose tissues of mice was detected by reverse transcription‑quantitative PCR. Mulberry leaf extract was found to reduce fat accumulation and hepatic lipid droplet formation. Mulberry leaf also alleviated inflammation and lipogenesis whilst promoting lipid catabolism and fatty acid oxidation by promoting the AMPK signaling pathway. The possible anti‑obesity effects of mulberry leaf on the mice may be due to the downregulation of TNF‑α, PPARD and PPARG and the upregulation of FAAH and HSD11B1. These results were consistent with the GO enrichment analysis and suggested that mulberry leaf may regulate lipid metabolism and catabolism, fatty acid metabolism and biosynthesis and the inflammatory response to reduce obesity.

View Figures

View References

1	Tsai AG and Bessesen DH: Obesity. Ann Intern Med. 170:ITC33–ITC48. 2019.PubMed/NCBI View Article : Google Scholar
2	Jia A, Xu S, Ming J, et al: Epidemic characteristics of obesity in China under various diagnostic criteria. Chin J Diabetes Mellitus. 9:221–225. 2017.(In Chinese).
3	Kim YJ, Lee HS, Kim YK, Park S, Kim JM, Yun JH, Yu HY and Kim BJ: Association of metabolites with obesity and Type 2 diabetes based on FTO genotype. PLoS One. 11(e0156612)2016.PubMed/NCBI View Article : Google Scholar
4	Lavie CJ, De Schutter A, Parto P, Jahangir E, Kokkinos P, Ortega FB, Arena R and Milani RV: Obesity and prevalence of cardiovascular diseases and Prognosis-The obesity paradox updated. Prog Cardiovasc Dis. 58:537–547. 2016.PubMed/NCBI View Article : Google Scholar
5	Yang XD, Jiang S, Wang G, Zhang R, Zhang J and Zhu JS: Link of obesity and gastrointestinal cancer: Crossroad of inflammation and oxidative stress. J Biol Regul Homeost Agents. 29:755–760. 2015.PubMed/NCBI
6	Wang R, Li Y, Mu W, Li Z, Sun J, Wang B, Zhong Z, Luo X, Xie C and Huang Y: Mulberry leaf extract reduces the glycemic indexes of four common dietary carbohydrates. Medicine (Baltimore. 97(e11996)2018.PubMed/NCBI View Article : Google Scholar
7	Park JM, Bong HY, Jeong HI, Kim YK, Kim JY and Kwon O: Postprandial hypoglycemic effect of mulberry leaf in Goto-Kakizaki rats and counterpart control Wistar rats. Nutr Res Pract. 3:272–278. 2009.PubMed/NCBI View Article : Google Scholar
8	Yang X, Yang L and Zheng H: Hypolipidemic and antioxidant effects of mulberry (Morus alba L.) fruit in hyperlipidaemia rats. Food Chem Toxicol. 48:2374–2379. 2010.PubMed/NCBI View Article : Google Scholar
9	Andallu B, Suryakantham V, Lakshmi Srikanthi B and Reddy GK: Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes. Clin Chim Acta. 314:47–53. 2001.PubMed/NCBI View Article : Google Scholar
10	Arabshahi-Delouee S and Urooj A: Antioxidant properties of various solvent extracts of mulberry (Morus indica L.) leaves. Food Chem. 102:1233–1240. 2007.
11	Ramadan EM, Abou-Taleb KA, Galal GF and Abdel-Hamid SN: Antibacterial, antibiofilm and antitumor activities of grape and mulberry leaves ethanolic extracts towards bacterial clinical strains. Ann Agric Sci. 62:151–159. 2017.
12	Zeni AL and Dall'Molin M: Hypotriglyceridemic effect of Morus alba L., Moraceae, leaves in hyperlipidemic rats. Rev Bras Farmacogn. 20:130–133. 2010.
13	Lee YJ, Choi DH, Kim EJ, Kim HY, Kwon TO, Kang DG and Lee HS: Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet. Am J Chin Med. 39:39–52. 2011.PubMed/NCBI View Article : Google Scholar
14	Peng CH, Lin HT, Chung DJ, Huang CN and Wang CJ: Mulberry leaf extracts prevent obesity-induced NAFLD with regulating adipocytokines, inflammation and oxidative stress. J Food Drug Anal. 26:778–787. 2018.PubMed/NCBI View Article : Google Scholar
15	Sheng Y, Liu J, Zheng S, Liang F, Luo Y, Huang K, Xu W and He X: Mulberry leaves ameliorate obesity through enhancing brown adipose tissue activity and modulating gut microbiota. Food Funct. 10:4771–4781. 2019.PubMed/NCBI View Article : Google Scholar
16	Li Q, Liu F, Liu J, Liao S and Zou Y: Mulberry leaf polyphenols and fiber induce synergistic antiobesity and display a modulation effect on gut microbiota and metabolites. Nutrients. 11(1017)2019.PubMed/NCBI View Article : Google Scholar
17	Yu G, Wang LG, Han Y and He QY: ClusterProfiler: An Rpackage for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012.PubMed/NCBI View Article : Google Scholar
18	Walter W, Sánchez-Cabo F and Ricote M: GOplot: An R package for visually combining expression data with functional analysis. Bioinformatics. 31:2912–2914. 2015.PubMed/NCBI View Article : Google Scholar
19	Ann JY, Eo H and Lim Y: Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis, fibrosis, and oxidative stress in high-fat diet-fed mice. Genes Nutr. 10(46)2015.PubMed/NCBI View Article : Google Scholar
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
21	Zhang RZ, Yu SJ, Bai H and Ning K: TCM-Mesh: The database and analytical system for network pharmacology analysis for TCM preparations. Sci Rep. 7(2821)2017.PubMed/NCBI View Article : Google Scholar
22	Li S: Network target: A starting point for traditional Chinese medicine network pharmacology. Zhongguo Zhong Yao Za Zhi. 36:2017–2020. 2011.PubMed/NCBI(In Chinese).
23	Tang H, He S, Zhang X, Luo S, Zhang B, Duan X, Zhang Z, Wang W, Wang Y and Sun Y: A network pharmacology approach to uncover the pharmacological mechanism of XuanHuSuo powder on osteoarthritis. Evid Based Complement Alternat Med. 2016(3246946)2016.PubMed/NCBI View Article : Google Scholar
24	Kim GN, Kwon YI and Jang HD: Mulberry leaf extract reduces postprandial hyperglycemia with few side effects by inhibiting α-glucosidase in normal rats. J Med Food. 14:712–717. 2011.PubMed/NCBI View Article : Google Scholar
25	Lee HJ, Na YG, Han M, Pham TMA, Lee H, Lee HK, Myung CS, Han JH, Kang JS, Kim KT and Cho CW: Statistical design of sustained-release tablet garcinia cambogia extract and bioconverted mulberry leaf extract for anti-obesity. Pharmaceutics. 12(932)2020.PubMed/NCBI View Article : Google Scholar
26	Aramwit P, Supasyndh O, Siritienthong T and Bang N: Mulberry leaf reduces oxidation and C-reactive protein level in patients with mild dyslipidemia. Biomed Res Int. 2013(787981)2013.PubMed/NCBI View Article : Google Scholar
27	Huang J, Wang Y, Ying C, Liu L and Lou Z: Effects of mulberry leaf on experimental hyperlipidemia rats induced by high-fat diet. Exp Ther Med. 16:547–556. 2018.PubMed/NCBI View Article : Google Scholar
28	Tian S, Wang M, Liu C, Zhao H and Zhao B: Mulberry leaf reduces inflammation and insulin resistance in type 2 diabetic mice by TLRs and insulin signalling pathway. BMC Complement Altern Med. 19(326)2019.PubMed/NCBI View Article : Google Scholar
29	Marcelino G, Machate DJ, Freitas KC, Hiane PA, Maldonade IR, Pott A, Asato MA, Candido CJ and Guimarães RCA: β-Carotene: Preventive role for type 2 diabetes mellitus and obesity: A review. Molecules. 25(5803)2020.PubMed/NCBI View Article : Google Scholar
30	Jiang H, Horiuchi Y, Hironao KY, Kitakaze T, Yamashita Y and Ashida H: Prevention effect of quercetin and its glycosides on obesity and hyperglycemia through activating AMPKα in high-fat diet-fed ICR mice. J Clin Biochem Nutr. 67:74–83. 2020.PubMed/NCBI View Article : Google Scholar
31	Kurano M, Hasegawa K, Kunimi M, Hara M, Yatomi Y, Teramoto T and Tsukamoto K: Sitosterol prevents obesity-related chronic inflammation. Biochim Biophys Acta Mol Cell Biol Lipids. 1863:191–198. 2018.PubMed/NCBI View Article : Google Scholar
32	Wang T, Wu Q and Zhao T: Preventive effects of kaempferol on high-fat diet-induced obesity complications in C57BL/6 mice. Biomed Res Int. 2020(4532482)2020.PubMed/NCBI View Article : Google Scholar
33	Mak IL, Lavery P, Agellon S, Rauch F, Murshed M and Weiler HA: Arachidonic acid exacerbates diet-induced obesity and reduces bone mineral content without impacting bone strength in growing male rats. J Nutr Biochem. 73(108226)2019.PubMed/NCBI View Article : Google Scholar
34	Yaribeygi H, Farrokhi FR, Butler AE and Sahebkar A: Insulin resistance: Review of the underlying molecular mechanisms. J Cell Physiol. 234:8152–8161. 2019.PubMed/NCBI View Article : Google Scholar
35	Hammarstedt A, Gogg S, Hedjazifar S, Nerstedt A and Smith U: Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity. Physiol Rev. 98:1911–1941. 2018.PubMed/NCBI View Article : Google Scholar
36	Poblete JMS, Ballinger MN, Bao S, Alghothani M, Nevado JB Jr, Eubank TD, Christman JW and Magalang UJ: Macrophage HIF-1α mediates obesity-related adipose tissue dysfunction via interleukin-1 receptor-associated kinase M. Am J Physiol Endocrinol Metab. 318:E689–E700. 2020.PubMed/NCBI View Article : Google Scholar
37	Yao L, Bhatta A, Xu Z, Chen J, Toque HA, Chen Y, Xu Y, Bagi Z, Lucas R, Huo Y, et al: Obesity-induced vascular inflammation involves elevated arginase activity. Am J Physiol Regul Integr Comp Physiol. 313:R560–R571. 2017.PubMed/NCBI View Article : Google Scholar
38	Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S, Jobin C and Lund PK: High-fat diet: Bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One. 5(e12191)2010.PubMed/NCBI View Article : Google Scholar
39	Tzanavari T, Giannogonas P and Karalis KP: TNF-alpha and obesity. Curr Dir Autoimmun. 11:145–156. 2010.PubMed/NCBI View Article : Google Scholar
40	Ding Y, Guo ZR, Wu M, Chen Q, Zhou ZY, Yu H, Zhang LJ, Liu JC and Luo WS: Effects of PPARD-87T >C and interactions with single nucleotide polymorphisms in PPARA and PPARG on abdominal obesity. Zhonghua Yi Xue Za Zhi. 92:1517–1521. 2012.PubMed/NCBI(In Chinese).
41	Landgraf K, Klöting N, Gericke M, Maixner N, Guiu-Jurado E, Scholz M, Witte AV, Beyer F, Schwartze JT, Lacher M, et al: The obesity-susceptibility gene TMEM18 promotes adipogenesis through activation of PPARG. Cell Rep. 33(108295)2020.PubMed/NCBI View Article : Google Scholar
42	Zhang Y, Sonnenberg GE, Baye TM, Littrell J, Gunnell J, DeLaForest A, MacKinney E, Hillard CJ, Kissebah AH, Olivier M and Wilke RA: Obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent. Pharmacogenomics. 10:1929–1939. 2009.PubMed/NCBI View Article : Google Scholar
43	Tomlinson JW, Moore JS, Clark PM, Holder G, Shakespeare L and Stewart PM: Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue. J Clin Endocrinol Metab. 89:2711–2716. 2004.PubMed/NCBI View Article : Google Scholar
44	Chedid MF, do Nascimento FV, de Oliveira FS, de Souza BM, Kruel CR, Gurski RR, Canani LH, Crispim D and Gerchman F: Interaction of HSD11B1 and H6PD polymorphisms in subjects with type 2 diabetes are protective factors against obesity: A cross-sectional study. Diabetol Metab Syndr. 11(78)2019.PubMed/NCBI View Article : Google Scholar
45	Zhu XJ, Dai JQ, Tan X, Zhao Y and Yang WJ: Activation of an AMP-activated protein kinase is involved in post-diapause development of Artemia franciscana encysted embryos. BMC Dev Biol. 9(21)2009.PubMed/NCBI View Article : Google Scholar
46	Hardie DG: New roles for the LKB1->AMPK pathway. Curr Opin Cell Biol. 17:167–173. 2005.PubMed/NCBI View Article : Google Scholar
47	Hardie DG: The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci. 117:5479–5487. 2004.PubMed/NCBI View Article : Google Scholar
48	Herzig S and Shaw RJ: AMPK: Guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 19:121–135. 2018.PubMed/NCBI View Article : Google Scholar
49	Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama T, et al: PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 4:597–609. 1999.PubMed/NCBI View Article : Google Scholar
50	Jones JR, Barrick C, Kim KA, Lindner J, Blondeau B, Fujimoto Y, Shiota M, Kesterson RA, Kahn BB and Magnuson MA: Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA. 102:6207–6212. 2005.PubMed/NCBI View Article : Google Scholar
51	Crewe C, Zhu Y, Paschoal VA, Joffin N, Ghaben AL, Gordillo R, Oh DY, Liang G, Horton JD and Scherer PE: SREBP-regulated adipocyte lipogenesis is dependent on substrate availability and redox modulation of mTORC1. JCI insight. 5(e129397)2019.PubMed/NCBI View Article : Google Scholar
52	Wu L, Zhang L, Li B, Jiang H, Duan Y, Xie Z, Shuai L and Li J and Li J: AMP-Activated Protein Kinase (AMPK) regulates energy metabolism through modulating thermogenesis in adipose tissue. Front Physiol. 9(122)2018.PubMed/NCBI View Article : Google Scholar
53	Jeon SM: Regulation and function of AMPK in physiology and diseases. Exp Mol Med. 48(e245)2016.PubMed/NCBI View Article : Google Scholar